Symbol
| FHL2
| contributors: mct/pgu - updated : 04-10-2023
|
HGNC name
| four and a half LIM domains 2
|
HGNC id
| 3703
|
corresponding disease(s)
|
CMD1H
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
in rhabdomyosarcoma | constitutional
|  
|  
|  
| loss of function
|
leads to impaired assembly of extracellular matrix proteins on the cell surface and to impaired bundling of focal adhesions | tumoral
|  
|  
|  
| gain of function
|
in colorectal cancer (CRC) compared with matched normal tissues | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | digestive | colon | |
FOXK1 and FHL2 may serve as putative targets in the combined therapy of colorectal cancer |
| | | |
| up-regulation of Fhl2 may contribute to the antihypertrophic phenotype that is observed in cardiac-specific Rock2-deficient mice |